Green tea and liver cancer

Affiliations

Editorial

Francesca Bravi et al. Hepatobiliary Surg Nutr. 2017 Apr.

. 2017 Apr;6(2):127-129.

doi: 10.21037/hbsn.2017.03.07.

¹ Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Green tea and liver cancer risk: A meta-analysis of prospective cohort studies in Asian populations.
Huang YQ, Lu X, Min H, Wu QQ, Shi XT, Bian KQ, Zou XP. Huang YQ, et al. Nutrition. 2016 Jan;32(1):3-8. doi: 10.1016/j.nut.2015.05.021. Epub 2015 Jul 2. Nutrition. 2016. PMID: 26412579 Review.

1. Lambert JD, Kennett MJ, Sang S, et al. Hepatotoxicity of high oral dose (-)-epigallocatechin-3-gallate in mice. Food Chem Toxicol 2010;48:409-16. 10.1016/j.fct.2009.10.030 - DOI - PMC - PubMed
1. Mazzanti G, Menniti-Ippolito F, Moro PA, et al. Hepatotoxicity from green tea: a review of the literature and two unpublished cases. Eur J Clin Pharmacol 2009;65:331-41. 10.1007/s00228-008-0610-7 - DOI - PubMed
1. Butler LM, Huang JY, Wang R, et al. Urinary biomarkers of catechins and risk of hepatocellular carcinoma in the Shanghai Cohort Study. Am J Epidemiol 2015;181:397-405. 10.1093/aje/kwu304 - DOI - PMC - PubMed
1. Bosetti C, Turati F, La Vecchia C. Hepatocellular carcinoma epidemiology. Best Pract Res Clin Gastroenterol 2014;28:753-70. 10.1016/j.bpg.2014.08.007 - DOI - PubMed
1. Hashim D, Boffetta P, La Vecchia C, et al. The global decrease in cancer mortality: trends and disparities. Ann Oncol 2016;27:926-33. 10.1093/annonc/mdw027 - DOI - PubMed